Codes / ICD10CM / D72.110

D72.110 Idiopathic hypereosinophilic syndrome [IHES]

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Idiopathic hypereosinophilic syndrome [IHES]
  • Medical Terms: Idiopathic hypereosinophilic syndrome

Summary

Idiopathic hypereosinophilic syndrome (IHES) is a rare disorder marked by persistently elevated eosinophil levels in the blood and tissues, leading to organ damage. It is a diagnosis of exclusion, meaning other causes of eosinophilia must be ruled out. The condition can affect multiple organ systems, including the heart, lungs, skin, and nervous system.

Causes

The exact cause of IHES is often unknown, though it may involve abnormal growth of eosinophils due to genetic mutations or dysregulated immune responses. Some cases are associated with clonal hematopoiesis, where eosinophils proliferate uncontrollably. In rare instances, it may be linked to underlying hematologic disorders.

Risk Factors

  • Persistent eosinophilia without a known cause
  • Family history of hematologic disorders
  • Exposure to certain medications or environmental triggers (e.g., allergens)
  • Underlying autoimmune or inflammatory conditions

Symptoms

  • Fatigue and weakness
  • Cough, shortness of breath, or chest pain (if lungs are involved)
  • Skin rashes, itching, or nodules
  • Abdominal pain, diarrhea, or nausea (if gastrointestinal tract is affected)
  • Neurological symptoms (e.g., confusion, numbness) in severe cases
  • Heart-related symptoms (e.g., palpitations, heart failure)

Diagnosis

Diagnosis involves blood tests to measure eosinophil levels. Further testing, such as allergy panels, imaging, or tissue biopsies, may be performed to identify an underlying cause, though the idiopathic code is used when no specific trigger is found.

Treatment Options

Treatment focuses on reducing eosinophil counts and managing organ damage. Options may include corticosteroids, targeted therapies, or immunosuppressants. In severe cases, hematopoietic stem cell transplantation may be considered.

Prognosis and Follow-Up

Prognosis varies depending on organ involvement and response to treatment. Regular monitoring of eosinophil levels and organ function is essential. Long-term follow-up is often required to manage complications and adjust therapy.

Complications

  • Organ damage (e.g., heart failure, lung fibrosis)
  • Blood clots (thromboembolism)
  • Neurological impairment
  • Skin or gastrointestinal complications

Lifestyle & Prevention

  • Avoid known allergens or triggers
  • Maintain regular medical check-ups
  • Follow prescribed treatment plans
  • Report new or worsening symptoms promptly

When to Seek Professional Help

Seek medical attention if experiencing persistent symptoms like unexplained fatigue, organ-specific pain, or signs of organ dysfunction (e.g., shortness of breath, chest pain, or neurological changes).

Tips for Medical Coders

Use D72.110 for idiopathic hypereosinophilic syndrome when the condition is diagnosed without a specified underlying cause. Ensure documentation supports the exclusion of other eosinophilic disorders and confirms persistent eosinophilia with organ involvement.

Book a walkthrough

D72.110 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.